NEXN and atherosclerosis: In recent clinical trials, atorvastatin has been shown to reduce the occurrence of pyroptosis in patients with atherosclerosis by up-regulating the lncRNA NEXN-AS1, and the NEXN-AS1 RNA level in vascular intimal plaques in patients with atherosclerosis is also significantly lower than in healthy intimal tissues.